Efficacy, safety and tolerability of IB-MS versus placebo in patients with progressive forms of MS: Preliminary results from a phase II, randomized, placebo-controlled, double blind, proof of concept study

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2018
This article has no abstract
Epistemonikos ID: 1a3078c46696b4679bde8298a099a1937bdbd42b
First added on: Apr 30, 2026